Navigation Links
Mach 7 Technologies Provides Optimized CT and MR Study Segmenting Software to Massachusetts General Hospital Imaging
Date:6/2/2010

BURLINGTON, Vt., June 2 /PRNewswire/ -- Mach 7 Technologies (M7T), a global provider of flexible, PACS-neutral healthcare image management solutions, has developed a state-of-the-art modality workstation application, the Keystone Study Split Utility (SSU), for Massachusetts General Hospital Imaging.  

The Keystone SSU will enable Mass General Imaging to improve workflow and enhance technologist productivity by reducing the time required for technologists to accurately split multi-region CT and MR scans (i.e. Chest-Abdomen-Pelvis) into anatomic regions that match the original orders from the RIS and reducing the time required for the newly split studies to be sent to the picture archiving communications system (PACS).  

With the new Keystone SSU application, radiologists who specialize in one region of the body will quickly get just the images they need to interpret while ensuring accurate billing for all orders entered into the system.  The efficient and accurate splitting of studies is important as a means of speeding time to diagnosis, enhancing patient care, and improving operational and business processes.  

"The Keystone Study Split Utility improves technologist workflow when splitting multi-region scans from CT or MR," notes Mary-Theresa Shore, Director of Clinical Operations at MGH.  "Based on initial testing data from the Keystone SSU clinical pilot, we are excited about the anticipated increased technologists' efficiency that the utility will deliver from scanner to PACS."

Designed for simplicity and continuity, the SSU receives multi-region studies and provides a straightforward work list interface from which studies can be selected for splitting by technologists. Once selected, the study loads quickly into the splitting interface at the Image level or Series level. From this intuitive user interface, technologists can easily highlight images or series and relate them to the original accession numbers (orders) derived from the DICOM Modality Worklist coming from the RIS or PACS broker.  If they haven't completed the exam in the RIS, the SSU automatically generates a reminder before allowing the technologist to split the study.  The SSU enables overlapping between anatomic regions and the ability to send the scout image and dosage report image or series with all of the resulting studies.  Once the split definition step is completed, the technologist initiates the split/send function with a minimum of clicks. The SSU then automatically splits the original study into the defined studies for each anatomical region and associates them to the proper accession numbers.  The SSU sends a Storage Commit Query to the PACS to auto-verify that the studies are in the PACS before purging them from memory.

"Our ability to rapidly incorporate feedback from the Mass General Imaging clinical operations team during the development of the Keystone SSU epitomizes the way Mach 7 Technologies partners with customers to deliver new and exciting image management solutions faster and with greater end-user customer input than other software developers," says Doug Schwab, VP and GM of Mach 7 Technologies. "The Keystone Study Split Utility demonstrates why Mach 7 Technologies is a rapidly-emerging provider of advanced, PACS-neutral, DICOM-based solutions."

About Mach 7 Technologies

Headquartered in Burlington, Vermont, Mach 7 Technologies is a global provider of innovative, flexible, PACS-neutral image management solutions that enable healthcare enterprises to better control, share and access medical imaging data.  Mach 7 Technologies develops software products that solve sophisticated image management challenges for hundreds of hospitals, imaging centers and clinics worldwide.  For additional information, please visit www.Mach7T.com.


'/>"/>
SOURCE Mach 7 Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
3. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
4. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
5. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
6. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
7. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
8. Senesco Technologies Initiates Preclinical Studies for Cancer Target
9. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
10. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
11. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 New Review ... Address Motor Symptoms and Motor Complications in Mid- ... ... (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
(Date:1/19/2017)... Marks E-QURE , s 3 ... similar agreements in Israel and Argentina ... 5 billion global market ... medical devices for the treatment of advanced wound care, announced today it signed ... Colombia for the Company,s patented Bio-electrical Signal Therapy device ("BST ...
(Date:1/19/2017)... Jan. 18, 2017  Magnetic Insight Inc., leader ... into an agreement with inviCRO LLC to develop ... imaging system based on inviCRO,s VivoQuant™ visualization and ... as a complete MPI solution package with the ... or cell imaging in vivo. MPI ...
Breaking Medicine Technology:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Source Vitál ... and 100 percent pure essential oils, announced the company had a successful visit to ... The annual ECRM event gives companies that work in the nutritional, sports and health ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice ... in families with school-aged children since the holiday season. , “It happens every ... their families, sharing hugs and taking photos, which is the head-to-head gateway that lice ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 ... For Betsy, the clinical trial has been life-saving as she has been on ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... ... You”: a fine examination of how God handles sin, including how to let go ... Miller, who, for over ten long years has been waiting to release this powerful insight ... he has been serving the Lord for over twenty years, and he has been preaching ...
Breaking Medicine News(10 mins):